Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Thymosin alpha 1 receives patent protection for hepatitis C indication

Aug. 24, 1998

Nabi files PLA, ELA for hepatitis B immune globulin

Aug. 21, 1998

New clinical study evaluating INKP-100 now in progress

Aug. 21, 1998

Selective beta3-adrenergic agents reported in development at Tokyo Tanabe

Aug. 19, 1998

Budesonide is superior to mesalamine in the treatment of Crohn's disease

Aug. 19, 1998

Results support development of beta-L-Fd4C as an expanded-spectrum anti-HBV drug

Aug. 18, 1998

FDA okays use of Engerix-B in patients with chronic HCV infection

Aug. 17, 1998

Results announced from primate studies of Nabi-Civacir

Aug. 17, 1998

New anti-H. pylori agents in development at Mitsubishi Chemical

Aug. 17, 1998

AU-006, a novel quinoline derivative with potent antiulcer activity

Aug. 14, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...